DK25691D0 - Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) - Google Patents

Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat)

Info

Publication number
DK25691D0
DK25691D0 DK025691A DK25691A DK25691D0 DK 25691 D0 DK25691 D0 DK 25691D0 DK 025691 A DK025691 A DK 025691A DK 25691 A DK25691 A DK 25691A DK 25691 D0 DK25691 D0 DK 25691D0
Authority
DK
Denmark
Prior art keywords
acat
cholesterol
bival
block
ligand compounds
Prior art date
Application number
DK025691A
Other languages
Danish (da)
English (en)
Other versions
DK25691A (da
Inventor
Ronald B Gammill
Frank P Bell
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK25691D0 publication Critical patent/DK25691D0/da
Publication of DK25691A publication Critical patent/DK25691A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK025691A 1988-08-16 1991-02-14 Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) DK25691A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23293188A 1988-08-16 1988-08-16
PCT/US1989/002572 WO1990002129A1 (en) 1988-08-16 1989-06-16 Bivalent ligands effective for blocking acat enzyme

Publications (2)

Publication Number Publication Date
DK25691D0 true DK25691D0 (da) 1991-02-14
DK25691A DK25691A (da) 1991-02-14

Family

ID=22875168

Family Applications (1)

Application Number Title Priority Date Filing Date
DK025691A DK25691A (da) 1988-08-16 1991-02-14 Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat)

Country Status (7)

Country Link
EP (1) EP0429464B1 (de)
JP (1) JPH04500506A (de)
KR (1) KR900701792A (de)
AT (1) ATE114311T1 (de)
DE (1) DE68919475T2 (de)
DK (1) DK25691A (de)
WO (1) WO1990002129A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304548A (en) * 1988-08-16 1994-04-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
US5180717A (en) * 1988-08-16 1993-01-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
WO1995027964A1 (en) * 1994-04-12 1995-10-19 Qualcomm Incorporated Method and apparatus for freight transportation using a satellite navigation system
EP2208728A4 (de) * 2007-09-19 2011-12-21 Inst Med Molecular Design Inc Heterocyclisches derivat mit hemmender wirkung auf 11-?-hydroxysteroiddehydrogenase vom typ i
EP2268644B1 (de) 2008-03-05 2011-08-17 Boehringer Ingelheim International GmbH Tricyclische pyridinderivate, solche verbindungen enthaltende medikamente, ihre verwendung und verfahren zu ihrer herstellung
PE20121743A1 (es) 2010-02-19 2012-12-22 Boehringer Ingelheim Int Derivados de piridina triciclicos, medicamentos que contienen tales compuestos, su uso y proceso para su preparacion
EP2760868B1 (de) 2011-08-17 2018-04-25 Boehringer Ingelheim International GmbH Furo[3,4-c]chinolinderivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
CN107021940A (zh) * 2017-05-03 2017-08-08 天津国际生物医药联合研究院 一种双哌嗪类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529561B2 (en) * 1979-02-13 1983-06-09 Upjohn Company, The Antiatherogenic 6-halofurochromones
US4412071A (en) * 1982-05-17 1983-10-25 The Upjohn Company Antiatherosclerotic compositions

Also Published As

Publication number Publication date
DE68919475T2 (de) 1995-05-11
EP0429464A1 (de) 1991-06-05
AU3835889A (en) 1990-03-23
AU631801B2 (en) 1992-12-10
KR900701792A (ko) 1990-12-04
JPH04500506A (ja) 1992-01-30
EP0429464B1 (de) 1994-11-23
WO1990002129A1 (en) 1990-03-08
DK25691A (da) 1991-02-14
ATE114311T1 (de) 1994-12-15
DE68919475D1 (de) 1995-01-05

Similar Documents

Publication Publication Date Title
NO904921D0 (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
DK246587A (da) 1-aralkylpyrazoler, fremgangsmaader til deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DK641589A (da) N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
DK362787A (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK25691D0 (da) Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat)
NO875263L (no) 2,3-disubstituerte isoksazolidiner, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse.
DK435588A (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
NO883244D0 (no) Aminoalkylerte hydroksyforbindelser og deres anvendelse som fungicider.
NO862975L (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK304090D0 (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
NO890894L (no) 4-substituerte pyrazolo(3,4-alfa)pyrimidinderivater og fremgangsmaate for deres fremstilling.
DK349688D0 (da) Bomologe af humant aprotinin, vaertsstamme samt ekspressionsvektorer til deres fremstilling og deres anvendelse som laegemidler
DK572785A (da) Imidazolderivater, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling
NO842938L (no) Antracycylinderivater, fremgangsmaate til deres fremstilling og deres anvendelse som cytostatika
NO840580L (no) Tributylfenol-etersulfonater, deres anvendelse og fremgangsmaate til fremstilling av etersulfonater
DK453184A (da) 1-azolyl-substituerede oximethere, fremgangsmaade til fremstilling deraf og deres anvendelse som fungicider
NO871375D0 (no) Bis-tertiaerbutylamino-substituerte 1,3,5-triazinderivater, fremgangsmaate til deres fremstilling, legemidler inneholdende disse forbindelser og deres anvendelse.
DK278986A (da) Halogenalkyl- eller halogenalkylsilylsubstituerede pyridaziner, deres fremstilling og anvendelse som fungicider
DK157187A (da) Acyloxyhiophencarboxamider, deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DK120789D0 (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
DK242289A (da) Diphenylsulfoner, -sulfider og -sulfoxider og deres virkning som modulatorer af immunresponssystemet
DK32487D0 (da) 2,4-diamino-6-halogenalkylpyrimidiner, fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
DK163175C (da) Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol
DK249486A (da) Fremgangsmaade til syntese af makromolekylaere, vandoplaeselige nicotinamid-adenin-derivater og anvendelse af saadanne i kontinuerte multienzymprocesser